<DOC>
	<DOCNO>NCT01494779</DOCNO>
	<brief_summary>The primary objective study compare pharmacokinetic pharmacodynamic effect two preparation somatropin ( T C ) single administration 5 mg healthy subject alter serum somatropin pharmacokinetic parameter ( AUC0-24h , AUC0-inf , Cmax , Tmax T1 / 2 ) pharmacodynamic ( measurement serum level IGF-1 present concentration-time profile , AUC 0-24h AUC0-inf . ) .</brief_summary>
	<brief_title>Evaluation Pharmacokinetic Pharmacodynamic Parameters Somatropin Produced Laboratory Blausiegel Indústria e Comércio Ltda. , Compared Saizen® From Laboratory Merck Serono S.A .</brief_title>
	<detailed_description>Secondly , investigator observe clinical safety tolerability single dose administration subject , compare clinical parameter incidence adverse event group .</detailed_description>
	<criteria>1 . Research subject agree study procedure , sign date , free , IC ; 2 . Research subject male , age 18 32 year ; 3 . Research subject body mass index great equal 20 less equal 25 ; 4 . Considered healthy subject , clinical laboratory . 1 . Have donate lose 450 mL blood 6 month precede study ; 2 . Having participate experimental study take experimental drug 12 month precede start study ; 3 . Having make use regular medication less two week interfere pharmacokinetics / pharmacodynamics drug study , glucocorticoid , anabolic steroid , androgen , estrogens thyroid hormone ; 4 . Present history alcohol abuse , drug drug ; 5 . Have history liver disease , renal , pulmonary , gastrointestinal , hematologic , psychiatric ; 6 . Have make previous use somatropin ; 7 . Make use energy supplement / frequent consumer soy product ( eg replacement animal milk soy milk ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>32 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>child</keyword>
</DOC>